Analyze Diet
Journal of the American Veterinary Medical Association2011; 239(6); 823-833; doi: 10.2460/javma.239.6.823

Evaluation of epidemiological, clinical, and pathological features of neuroaxonal dystrophy in Quarter Horses.

Abstract: To describe epidemiological, clinical, and pathological features of neuroaxonal dystrophy in Quarter Horses (QHs) on a single farm. Methods: Prospective case series. Animals-148 horses. Methods: Neurologic, pathological, and toxicological evaluations were completed in selected neurologically affected horses over a 2-year period. Descriptive statistical analysis was performed. Results: 87 QHs and 1 QH-crossbred horse were affected. Most (50/88 [56.8%]) affected horses were 1 to 2 years old (median age, 2 years [range, 2 months to 34 years]). Neurologic deficits included obtundation (53/88 [60%] horses), decreased to absent menace response (33/88 [37.5%]), proprioceptive positioning deficits, wide-based stance, ataxia, and dysmetria (88/88 [100%]). Most (78/88 [88.6%]) horses had mild ataxia, but some (10/88 [11.4%]) had moderate to severe ataxia. Low serum concentrations of vitamin E (≤ 2 mg/L) were detected in 3 index case horses and 16 of 17 randomly selected horses (13/14 affected and 3/3 unaffected) during study year 1. Dietary vitamin E supplementation did not improve neurologic deficits in affected horses; vitamin E administration in pregnant mares appeared to decrease but not prevent disease development among offspring born the following year. Lesions detected at necropsy included bilaterally symmetric neuroaxonal degeneration with axonal spheroids in the nucleus gracilis, nucleus cuneatus medialis, nucleus cuneatus lateralis, and nucleus thoracicus (5/5 horses). Conclusions: Neuroaxonal dystrophy should be considered in evaluation of young horses with ataxia and proprioceptive positioning deficits. Vitamin E deficiency may contribute to disease severity.
Publication Date: 2011-09-16 PubMed ID: 21916766DOI: 10.2460/javma.239.6.823Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research study outlines the features of neuroaxonal dystrophy (a neurological disorder) in Quarter Horses from a single farm, examining the epidemiological, clinical, and pathological aspects of the disorder, along with the role of vitamin E deficiency as a possible contributing factor.

Epidemiological and clinical evaluation

  • The study involved a prospective case series, including 148 Quarter Horses.
  • Neuroaxonal dystrophy was found in 87 Quarter Horses and 1 Quarter Horse-crossbred, predominantly affecting horses aged 1 to 2 years.
  • Clinical symptoms included obtundation (a decrease in alertness or consciousness), decreased menace response (an automatic closing of the eyelids in response to an approaching object), proprioceptive positioning deficits (loss of body position sense and balance), wide stance, ataxia (lack of muscle control or coordination), and dysmetria (a lack of control over the range of movement).
  • The majority of affected horses (88.6%) showed mild ataxia, while 11.4% had moderate to severe ataxia.

Pathological and toxicological evaluations

  • The study involved detailed neurological, pathological, and toxicological evaluations of selected horses that presented neurological symptoms.
  • The evaluations showed low serum concentrations of vitamin E in the affected horses, which implies a possible link between vitamin E deficiency and the disease severity.
  • However, dietary supplementation of vitamin E did not show improvement in the neurological deficits in the affected horses.
  • Data suggests that administering vitamin E to pregnant mares slightly decreased the occurrence of neuroaxonal dystrophy in their offspring, but did not prevent the disease entirely.

Necropsy findings and conclusion.

  • Examination of horses after death revealed lesions typical of neuroaxonal degeneration, located in various nuclei (clusters of nerve cells) in the spinal cord.
  • The study concludes that neuroaxonal dystrophy should be considered in young horses showing symptoms of ataxia and proprioceptive dysfunction.
  • While vitamin E deficiency may exacerbate the disease, its supplementation did not alleviate the neurological symptoms, suggesting other factors should be investigated for the development and progression of this disorder in horses.

Cite This Article

APA
Aleman M, Finno CJ, Higgins RJ, Puschner B, Gericota B, Gohil K, LeCouteur RA, Madigan JE. (2011). Evaluation of epidemiological, clinical, and pathological features of neuroaxonal dystrophy in Quarter Horses. J Am Vet Med Assoc, 239(6), 823-833. https://doi.org/10.2460/javma.239.6.823

Publication

ISSN: 1943-569X
NlmUniqueID: 7503067
Country: United States
Language: English
Volume: 239
Issue: 6
Pages: 823-833

Researcher Affiliations

Aleman, Monica
  • William R. Pritchard Veterinary Medical Teaching Hospital, School of Medicine, University of California-Davis, Davis, CA 95616, USA. mraleman@ucdavis.edu
Finno, Carrie J
    Higgins, Robert J
      Puschner, Birgit
        Gericota, Barbara
          Gohil, Kishorchandra
            LeCouteur, Richard A
              Madigan, John E

                MeSH Terms

                • Aging
                • Animals
                • Carrier Proteins / genetics
                • Carrier Proteins / metabolism
                • Dietary Supplements
                • Electroencephalography / veterinary
                • Female
                • Gene Expression Regulation / physiology
                • Horse Diseases / drug therapy
                • Horse Diseases / etiology
                • Horse Diseases / pathology
                • Horses
                • Male
                • Neuroaxonal Dystrophies / etiology
                • Neuroaxonal Dystrophies / pathology
                • Neuroaxonal Dystrophies / veterinary
                • Pregnancy
                • RNA, Messenger / genetics
                • RNA, Messenger / metabolism
                • Vitamin E / therapeutic use
                • Vitamin E Deficiency / complications
                • Vitamin E Deficiency / diagnosis
                • Vitamin E Deficiency / pathology
                • Vitamin E Deficiency / veterinary

                Citations

                This article has been cited 27 times.
                1. Donnelly CG, Finno CJ. Vitamin E depletion is associated with subclinical axonal degeneration in juvenile horses. Equine Vet J 2023 Sep;55(5):884-890.
                  doi: 10.1111/evj.13907pubmed: 36516303google scholar: lookup
                2. Hales EN, Habib H, Favro G, Katzman S, Sakai RR, Marquardt S, Bordbari MH, Ming-Whitfield B, Peterson J, Dahlgren AR, Rivas V, Ramirez CA, Peng S, Donnelly CG, Dizmang BS, Kallenberg A, Grahn R, Miller AD, Woolard K, Moeller B, Puschner B, Finno CJ. Increased α-tocopherol metabolism in horses with equine neuroaxonal dystrophy. J Vet Intern Med 2021 Sep;35(5):2473-2485.
                  doi: 10.1111/jvim.16233pubmed: 34331715google scholar: lookup
                3. Hales EN, Aleman M, Marquardt SA, Katzman SA, Woolard KD, Miller AD, Finno CJ. Postmortem diagnoses of spinal ataxia in 316 horses in California. J Am Vet Med Assoc 2021 Jun 15;258(12):1386-1393.
                  doi: 10.2460/javma.258.12.1386pubmed: 34061609google scholar: lookup
                4. Aleman M, Berryhill E, Woolard K, Easton-Jones CA, Kozikowski-Nicholas T, Dyson S, Kilcoyne I. Sidewinder gait in horses. J Vet Intern Med 2020 Sep;34(5):2122-2131.
                  doi: 10.1111/jvim.15870pubmed: 32820825google scholar: lookup
                5. Rijckaert J, Raes E, Buczinski S, Dumoulin M, Deprez P, Van Ham L, van Loon G, Pardon B. Accuracy of transcranial magnetic stimulation and a Bayesian latent class model for diagnosis of spinal cord dysfunction in horses. J Vet Intern Med 2020 Mar;34(2):964-971.
                  doi: 10.1111/jvim.15699pubmed: 32030834google scholar: lookup
                6. Hales EN, Esparza C, Peng S, Dahlgren AR, Peterson JM, Miller AD, Finno CJ. Genome-Wide Association Study and Subsequent Exclusion of ATCAY as a Candidate Gene Involved in Equine Neuroaxonal Dystrophy Using Two Animal Models. Genes (Basel) 2020 Jan 10;11(1).
                  doi: 10.3390/genes11010082pubmed: 31936863google scholar: lookup
                7. Bookbinder L, Finno CJ, Firshman AM, Katzman SA, Burns E, Peterson J, Dahlgren A, Ming-Whitfield B, Glessner S, Borer-Matsui A, Valberg SJ. Impact of alpha-tocopherol deficiency and supplementation on sacrocaudalis and gluteal muscle fiber histopathology and morphology in horses. J Vet Intern Med 2019 Nov;33(6):2770-2779.
                  doi: 10.1111/jvim.15643pubmed: 31660648google scholar: lookup
                8. Marquardt SA, Wilcox CV, Burns EN, Peterson JA, Finno CJ. Previously Identified Genetic Variants in ADGRL3 Are not Associated with Risk for Equine Degenerative Myeloencephalopathy across Breeds. Genes (Basel) 2019 Sep 5;10(9).
                  doi: 10.3390/genes10090681pubmed: 31491999google scholar: lookup
                9. Burns EN, Finno CJ. Equine degenerative myeloencephalopathy: prevalence, impact, and management. Vet Med (Auckl) 2018;9:63-67.
                  doi: 10.2147/VMRR.S148542pubmed: 30234005google scholar: lookup
                10. Finno CJ, Estell KE, Winfield L, Katzman S, Bordbari MH, Burns EN, Miller AD, Puschner B, Tran CK, Xu L. Lipid peroxidation biomarkers for evaluating oxidative stress in equine neuroaxonal dystrophy. J Vet Intern Med 2018 Sep;32(5):1740-1747.
                  doi: 10.1111/jvim.15241pubmed: 30133798google scholar: lookup
                11. Lucot KL, Dickinson PJ, Finno CJ, Mansour TA, Letko A, Minor KM, Mickelson JR, Drögemüller C, Brown CT, Bannasch DL. A Missense Mutation in the Vacuolar Protein Sorting 11 (VPS11) Gene Is Associated with Neuroaxonal Dystrophy in Rottweiler Dogs. G3 (Bethesda) 2018 Jul 31;8(8):2773-2780.
                  doi: 10.1534/g3.118.200376pubmed: 29945969google scholar: lookup
                12. Tsuboi M, Watanabe M, Nibe K, Yoshimi N, Kato A, Sakaguchi M, Yamato O, Tanaka M, Kuwamura M, Kushida K, Ishikura T, Harada T, Chambers JK, Sugano S, Uchida K, Nakayama H. Identification of the PLA2G6 c.1579G>A Missense Mutation in Papillon Dog Neuroaxonal Dystrophy Using Whole Exome Sequencing Analysis. PLoS One 2017;12(1):e0169002.
                  doi: 10.1371/journal.pone.0169002pubmed: 28107443google scholar: lookup
                13. Finno CJ, Bordbari MH, Valberg SJ, Lee D, Herron J, Hines K, Monsour T, Scott E, Bannasch DL, Mickelson J, Xu L. Transcriptome profiling of equine vitamin E deficient neuroaxonal dystrophy identifies upregulation of liver X receptor target genes. Free Radic Biol Med 2016 Dec;101:261-271.
                14. Finno CJ, Kaese HJ, Miller AD, Gianino G, Divers T, Valberg SJ. Pigment retinopathy in warmblood horses with equine degenerative myeloencephalopathy and equine motor neuron disease. Vet Ophthalmol 2017 Jul;20(4):304-309.
                  doi: 10.1111/vop.12417pubmed: 27491953google scholar: lookup
                15. Finno CJ, Miller AD, Sisó S, Divers T, Gianino G, Barro MV, Valberg SJ. Concurrent Equine Degenerative Myeloencephalopathy and Equine Motor Neuron Disease in Three Young Horses. J Vet Intern Med 2016 Jul;30(4):1344-50.
                  doi: 10.1111/jvim.13977pubmed: 27298214google scholar: lookup
                16. Díez de Castro E, Zafra R, Acevedo LM, Pérez J, Acosta I, Rivero JL, Aguilera-Tejero E. Eosinophilic Enteritis in Horses with Motor Neuron Disease. J Vet Intern Med 2016 May;30(3):873-9.
                  doi: 10.1111/jvim.13944pubmed: 27015868google scholar: lookup
                17. Finno CJ, Estell KE, Katzman S, Winfield L, Rendahl A, Textor J, Bannasch DL, Puschner B. Blood and Cerebrospinal Fluid α-Tocopherol and Selenium Concentrations in Neonatal Foals with Neuroaxonal Dystrophy. J Vet Intern Med 2015 Nov-Dec;29(6):1667-75.
                  doi: 10.1111/jvim.13618pubmed: 26391904google scholar: lookup
                18. Finno CJ, Valberg SJ, Shivers J, D'Almeida E, Armién AG. Evidence of the Primary Afferent Tracts Undergoing Neurodegeneration in Horses With Equine Degenerative Myeloencephalopathy Based on Calretinin Immunohistochemical Localization. Vet Pathol 2016 Jan;53(1):77-86.
                  doi: 10.1177/0300985815598787pubmed: 26253880google scholar: lookup
                19. Aleman M, Dimock AN, Wisner ER, Prutton JW, Madigan JE. Atlanto-axial approach for cervical myelography in a Thoroughbred horse with complete fusion of the atlanto-occipital bones. Can Vet J 2014 Nov;55(11):1069-73.
                  pubmed: 25392550
                20. Finno CJ, Aleman M, Higgins RJ, Madigan JE, Bannasch DL. Risk of false positive genetic associations in complex traits with underlying population structure: a case study. Vet J 2014 Dec;202(3):543-9.
                  doi: 10.1016/j.tvjl.2014.09.013pubmed: 25278384google scholar: lookup
                21. Finno CJ, Famula T, Aleman M, Higgins RJ, Madigan JE, Bannasch DL. Pedigree analysis and exclusion of alpha-tocopherol transfer protein (TTPA) as a candidate gene for neuroaxonal dystrophy in the American Quarter Horse. J Vet Intern Med 2013 Jan-Feb;27(1):177-85.
                  doi: 10.1111/jvim.12015pubmed: 23186252google scholar: lookup
                22. Willis AT, Dahlgren AR, Woolard KD, Ghosh S, Donnelly CG, de la Concha-Bermejillo A, Pacheco A, Watson KD, Berryhill E, Aleman M, Wensley F, Humphreys S, Whitehead AE, Goldsmith D, Chesen B, Ragsdale J, Tompkins JE, Nash R, Plunkett AH, Qualls HJ, Rodriguez K, Hochanadel D, Miller AD, Finno CJ. Clinicopathological and pedigree investigation of a novel spinocerebellar neurological disease in juvenile Quarter Horses in North America. J Vet Intern Med 2024 May-Jun;38(3):1808-1814.
                  doi: 10.1111/jvim.17049pubmed: 38669583google scholar: lookup
                23. Powers A, Peek SF, Reed S, Donnelly CG, Tinkler S, Gasper D, Woolard KD, Finno CJ. Equine neuroaxonal dystrophy/degenerative myeloencephalopathy in Gypsy Vanner horses. J Vet Intern Med 2024 May-Jun;38(3):1792-1798.
                  doi: 10.1111/jvim.17062pubmed: 38613444google scholar: lookup
                24. Palmisano M, Kulp J, Bender S, Stefanovski D, Robinson M, Johnson A. Measurement of 8-hydroxy-2'-deoxyguanosine in serum and cerebrospinal fluid of horses with neuroaxonal degeneration and other causes of proprioceptive ataxia. J Vet Intern Med 2024 Mar-Apr;38(2):1207-1213.
                  doi: 10.1111/jvim.16988pubmed: 38205913google scholar: lookup
                25. Brown KA, Bender SJ, Johnson AL. Clinical and histopathological features in horses with neuroaxonal degeneration: 100 cases (2017-2021). J Vet Intern Med 2024 Jan-Feb;38(1):431-439.
                  doi: 10.1111/jvim.16969pubmed: 38095342google scholar: lookup
                26. Ma Y, Peng S, Donnelly CG, Ghosh S, Miller AD, Woolard K, Finno CJ. Genetic polymorphisms in vitamin E transport genes as determinants for risk of equine neuroaxonal dystrophy. J Vet Intern Med 2024 Jan-Feb;38(1):417-423.
                  doi: 10.1111/jvim.16924pubmed: 37937700google scholar: lookup
                27. Williams Louie E, Nieto J, Wensley F, Morgan JM, Finno CJ, Berryhill EH. Efficacy of the oral supplement, Equine Omega Complete, for the prevention of gastric ulcers and alpha-tocopherol supplementation in horses. J Vet Intern Med 2023 Nov-Dec;37(6):2529-2534.
                  doi: 10.1111/jvim.16877pubmed: 37775973google scholar: lookup